Simon Cowell is known for being a tough and brutally honest judge on TV talent shows. He is a producer and the creator of popular shows like *The X Factor* and *America’s Got Talent*, and he has done very well for himself throughout his career. Despite his tough TV persona, Simon Cowell is now a caring father. He has said that none of his $600 million fortune will go to his son, Eric. Instead, he plans to donate all of it to charity.
Simon Cowell is a very successful entertainment business owner, producer, and TV personality, known for judging talent competitions in both the UK and the United States. Now, he can add another role to his list: he is a father. Cowell became a father in 2014, a moment that he says changed him as a person. However, before the birth of his son, Eric, he mentioned in an interview that none of his $600 million fortune would be passed on to his son. He believes that passing down wealth to the next generation is not the right thing to do.
“I’m going to leave my money to someone—probably a charity, like kids and dogs,” Simon Cowell said in 2013. He believes in leaving a legacy instead of just passing down money to his son. Cowell thinks that helping his son develop a successful career is more important than giving him a lot of money.
“The goal is to give people opportunities so they can succeed, and to share your knowledge with them,” he explained. Simon Cowell’s net worth is around $600 million, and he plans to donate all of it to charity. He hasn’t decided which charity yet, but he mentioned it will likely be related to children or dogs.
Simon Cowell is not the only celebrity who has said their money will go to charity instead of their children. Famous TV anchor Anderson Cooper shares similar views. He welcomed his child via surrogacy in 2020 and said, “I don’t believe in passing on huge amounts of money. I’m not that interested in money, but I don’t plan to have a pot of gold for my son. My parents taught me that college will be paid for, and then he needs to get to work.”
One of the world’s richest people, Microsoft founder Bill Gates, has also promised that his children won’t inherit his billions. Most of his wealth, along with that of his ex-wife Melinda Gates, will go to the Bill and Melinda Gates Foundation. This foundation aims to eliminate poverty, hunger, and disease worldwide. Gates explained, “It’s not a favor to kids to give them huge sums of wealth. It can distort their path.”
Other celebrities who also believe in not passing down wealth include Jackie Chan, Mark Zuckerberg, Warren Buffett, Gordon Ramsay, Ashton Kutcher, Mila Kunis, and Sir Elton John. Zuckerberg and his wife said on Facebook, “We have a moral responsibility to all children in the next generation. Our main focuses will be personalized learning, curing disease, connecting people, and building strong communities.”
Meet Twins with the Rare Benjamin Button Syndrome, Who Became Symbols of Resilience
In a small Brazilian town, there resides an extraordinary duo of identical twins named Elis and Eloá. Their story serves as a beacon of resilience and the remarkable power of the human spirit. Afflicted with Hutchinson-Gilford Progeria Syndrome, a rare and fatal genetic disorder causing accelerated aging, these twins confront their adversities with remarkable grace and strength, earning admiration from people worldwide.
Understanding Hutchinson-Gilford Progeria syndrome
HGPS stands as an exceptionally rare disorder, impacting roughly 1 in 20 million newborns globally. Marked by rapid aging from early childhood, individuals with progeria often display growth delays, diminished body fat and hair, prematurely aged skin, joint stiffness, and severe cardiovascular issues. Typically, those with HGPS have an average life expectancy of about 14.5 years, though some may extend into their late teens or early twenties. This syndrome gained public attention through the film The Curious Case of Benjamin Button.
The condition is caused by a mutation in the LMNA gene, which produces the lamin A protein responsible for maintaining the structural integrity of the cell nucleus. The mutation results in the production of an abnormal version of the protein, called progerin, which causes cells to become unstable and die prematurely.
Elis and Eloá’s journey
Elis and Eloá swiftly captured attention because of their distinctive medical condition. Despite the physical hurdles imposed by progeria, their contagious smiles and steadfast optimism have emerged as beacons of hope and inspiration. Guilherme and Elismar, the twins’ parents, have dedicated their lives to offering the utmost care for their daughters, striving to ensure they experience as normal a life as feasible within the confines of their condition.
The family’s path has been far from easy. Their daily life is filled with demanding medical routines, including physiotherapy, aimed at addressing joint stiffness and preserving mobility. Despite these challenges, Elis and Eloá approach each day with remarkable bravery and an unparalleled enthusiasm for life, which is truly remarkable.
A global community of support
Elis and Eloá’s narrative has touched hearts worldwide, sparking a surge of solidarity from individuals and groups committed to promoting awareness about progeria and backing research endeavors. The Progeria Research Foundation, a pivotal entity in this realm, has played a vital role in propelling research forward and furnishing assistance to families grappling with the condition.
Through social media platforms, the twins’ journey is shared with a broad audience, fostering a sense of community and solidarity. Their family’s updates, documenting both the highs and lows of their daily lives, provide invaluable insights into the realities of living with progeria, while also spreading a message of hope and perseverance.
Advances in research and hope for the future
In recent years, there have been remarkable advancements in comprehending and addressing progeria. A notable milestone occurred in 2020 when the U.S. Food and Drug Administration (FDA) granted approval for the first progeria treatment: lonafarnib. This medication has demonstrated efficacy in prolonging the lives of children with progeria by mitigating the accumulation of progerin in cells, thereby decelerating the disease’s advancement.
Though a cure remains elusive, ongoing research presents promising prospects. Scientists are delving into gene-editing methodologies, like CRISPR, as potential means to rectify the genetic mutation at its root. For families such as Elis and Eloá’s, these breakthroughs offer a ray of hope for the future.
And in our other article, we recounted the remarkable story of a girl born without a nose, affectionately dubbed “Voldemort,” who refuses to let her differences define her.
Leave a Reply